About this trial
Pulmonary hypertension (PH) is a major global health concern, affecting approximately 1% of the world's population. With global aging and increased life expectancy, its incidence continues to rise. PH is a progressive and disabling disease, with studies showing its progression correlates with worsening symptoms and increased mortality. Even with targeted medications, the prognosis remains poor across PH subtypes, with PAH patients showing only a 49% 7-year survival rate. The 2022 ESC/ERS guidelines emphasize that PH management requires a comprehensive, multidisciplinary approach. Beyond pharmacological and surgical treatments, rehabilitation has demonstrated benefits in improving exercise capacity, quality of life, functional class, and peak oxygen consumption. However, research on specific and effective comprehensive pulmonary rehabilitation programs remains lacking.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Group 1 (PAH) or
Group 4 (CTEPH/other pulmonary artery obstructions)
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Comprehensive Pulmonary Rehabilitation Program
BehavioralCombined Aerobic + Resistance Training Program Mode: Cycle ergometry (stationary bicycle) Frequency: 3-5 sessions per week Program Duration: 12 weeks Session Structure: * 5-minute warm-up * Continuous or interval training (15-30 minutes) * 5-minute cool-downesistance Exercise Component Mode: Dumbbell exercises + cycle ergometry Frequency: 3 sessions per week Program Duration: 12 weeks Session Structure: * 5-minute warm-up * Training session (10-20 minutes) * 5-minute cool-down
Standard Pulmonary Rehabilitation
Behavioralxercise Components: Aerobic Exercise Mode: Walking or jogging Resistance Exercise Mode: Elastic bands or dumbbells Training Parameters: Session Duration: ≥35 minutes (combined aerobic + resistance) Frequency: 3-5 sessions per week Program Duration: 12 weeks
Treatment groups
Trial outcomes
Primary outcomes
6MWD
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Beijing Chao Yang Hospital
Lead sponsor
Beijing Municipal Health Commission
Collaborator
This trial is not recruiting at the moment. You can still explore other options: